News
Videos
Conferences
Events
Resources
Subscribe

|Articles|October 2, 2017

Take the CURE Magazine Survey

Author(s)Staff

Thank you for answering the questions below.

Newsletter

Stay up to date on cancer updates, research and education

Related Content

multiple myeloma

Off-The-Shelf CAR-T KLN-1010 Associated With Deep Responses in R/R Myeloma

ByCourtney Flaherty

December 10th 2025

Bonnie Annis

A Closet Full of Boobs and the Thought That Caught Me by Surprise

December 9th 2025

follicular lymphoms

Yescarta Shows Durable Responses and Manageable Safety in Real-World R/R FL

December 9th 2025

Dexamethasone before Yescarta reduced the severity of ICANS but did not change how often ICANS or CRS occurred in patients with LBCL.

Dexamethasone May Ease Severe Neurotoxicity With Yescarta in LBCL

December 9th 2025

Pelabresib plus Jakafi delivered stronger, clinically meaningful benefits versus Jakafi alone for people with untreated myelofibrosis.

New Data Support Pelabresib Combination in Untreated Myelofibrosis

December 9th 2025

Trending on CURE

Real-Time Text Tool Tracks Quality of Life in Myeloma Care

Breaking Down the Prostate Cancer Treatment Renaissance

Tecvayli Treatment Combo Improves Outcomes in Relapsed/Refractory Myeloma

Epkinly Plus Chemo Elicits Durable Responses in DLBCL

A Closet Full of Boobs and the Thought That Caught Me by Surprise

© 2025 MJH Life Sciences^®

All rights reserved.